Decrease of CSF dopamine, its metabolites and noradrenalin after withdrawal of chronic neuroleptic treatment in schizophrenic patients.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004298:Dopamine / Q000134:cerebrospinal fluid*; D006801:Humans; D009638:Norepinephrine / Q000134:cerebrospinal fluid*; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy*
D014150:Antipsychotic Agents; D004298:Dopamine; D009638:Norepinephrine